The Cobalt-Lym Study Of Ctx130: A Phase 1 Dose Escalation Study Of Cd70-Targeted Allogeneic Crispr-Cas9-Engineered Car T Cells In Patients With Relapsed/Refractory (R/R) T-Cell Malignancies
CTX-130
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: The Cobalt-Lym Study Of Ctx130: A Phase 1 Dose Escalation Study Of Cd70-Targeted Allogeneic Crispr-Cas9-Engineered Car T Cells In Patients With Relapsed/Refractory (R/R) T-Cell Malignancies ### Output: CTX-130